Transcatheter Mitral-Valve Repair in Patients with Heart Failure

Short summary

Transcatheter mitral-valve repair reduced heart failure hospitalizations by 47% (35.8% vs. 67.9% per patient-year) and all-cause mortality by 37% (29.1% vs. 46.1%) over 24 months in symptomatic heart failure patients with secondary mitral regurgitation.

AI-generated from the title and abstract; the full text is not read.